KTN's online platform helps you to make the connections you need

 

The Knowledge Transfer Network (KTN) has refreshed its online platform to intelligently connect you to relevant events, funding, thought pieces and specialist staff to help your business innovate and grow.

You can discover content using your area of interest, from Defence Security to transport; from space to health – all major UK economic sectors are covered. Once you have selected your interests, using our intelligent tagging system, we will then display rich and relevant content related to your area, often from surprising sources.

An example might be new satellite technology from the space sector that is applicable in the agri-food sector. KTN-UK.co.uk will help you form these unusual and valuable connections.

All content on the platform has been carefully curated by our team of innovation specialists – not by an automated algorithm – so you can be confident that KTN is connecting you to the most relevant cutting-edge information.

 

The move also marks a closer alignment with our main funder, Innovate UK , with the website branding making a clear visual link. Knowledge Transfer Network is Innovate UK's innovation network partner, and also works with other funders to provide innovation networking services and fulfil our mission to drive UK growth.

We link new ideas and opportunities with expertise, markets and finance through our network of businesses, universities, funders and investors. From agri-food to autonomous systems and from energy to design, KTN combines expertise in all sectors with the ability to cross boundaries. Connecting with KTN can lead to potential partners, horizon-expanding events and innovation insights relevant to your needs.

Visit our people pages to connect directly with expertise in your sector.

Visit the KTN refreshed online platfom here

« go back

Advanced Therapies and Medicinal Products Ministerial Taskforce Update

The Advanced Therapies Manufacturing Taskforce originated from the work of the Medicines Manufacturing Industry Partership (MMIP), it is co-chaired by George Freeman MP, Minister for Life Sciences, and by me, the Chair of the MMIP. It is a short-term group which will meet three times over 2016 with the aim of anchoring advanced therapy manufacturing and its associated supply chain in the UK. It will make a small number of targeted recommendations through an action and deliver plan to achieve this aim.

Taskforce membership
The group’s members include senior representatives from:
  • Office for Life Sciences
  • GSK
  • GE Healthcare
  • Pfizer
  • Astrazeneca
  • Cell and Gene Therapy Catapult
  • Centre for Process Innovation
  • Innovate UK
  • MRC
  • Institute for Manufacturing
  • MHRA
  • NHS Blood and Transplant
  • University College London
  • Oxford BioMedica
  • ReNeuron
  • Autolus
  • Cobra Biologics
Taskforce workstreams
The Taskforce has created three workstreams and appointed three leaders:
  • Technology and manufacturing (Keith Thompson, Cell and Gene Therapy Catapult)
    This workstream is looking at the current UK manufacturing position and considering a range of ideas from flexible grant and loan schemes to greater support infrastructure for companies.
  • People, skills & training (Jim Faulkner, Autolus)
    This is the most narrowly focused of the workstreams, it is looking at both training new people to enter the industry and repurposing existing skilled individuals to work specifically on ATMPs.
  • International competitiveness (Roger Connor, GSK)
    This workstream is looking at where intervention is required to support the UK’s ability to compete globally for manufacturing investment in advanced therapies. It is identifying where the UK is already strong and considering the UK’s process development capability, fiscal environment and the route to market for advanced therapies.
Next steps
 
The next meeting of the Ministerial Taskforce will be on Tuesday 28 June. At this meeting workstreams will submit initial proposals for recommendations to anchor advanced therapy manufacturing in the UK. After this meeting, details of a survey will be shared to ensure that the suggested actions reflect the views of the wider community. A final action and delivery plan will then be drafted ahead of the Taskforce’s third and final meeting on 2 November, with a release date for the plan and follow-up steps yet to be announced.